Skip to main content
. 2016 Aug 11;37(10):965–971. doi: 10.1093/carcin/bgw082

Table 3.

The associations between identified SNPs and risk of GS 4+3 disease

GS 4+3 versus GS 3+4
SNP Risk allele OR (95% CI) P value
rs752822 T 1.44 (1.12–1.87) 4.76×10−3
rs9883073 A 0.98 (0.79–1.23) 0.884
rs55868746 A 1.04 (0.62–1.74) 0.875
rs72840119a C 1.02 (0.62–1.67) 0.934
rs10885398 G 1.09 (0.85–1.40) 0.483

The models were adjusted for age, clinical tumor stage and PSA levels at diagnosis. Additive genetic model was tested for all SNPs.

aaSNP in moderate LD (R2 = 0.6–0.8) with rs55868746.